Blood Detection of EGFR Mutation For Iressa Treatment
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Gefitinib (Primary)
- Indications Lung cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms BENEFIT
- 22 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.
- 22 Feb 2017 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2017.
- 22 Feb 2017 Status changed from recruiting to active, no longer recruiting.